Community/research information onlyNot FDA/EMA approved
Community protocol · Selank
Selank: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: SK · TP-7 · Tuftsin analogue
Sources checked: 27 August 2026
Important safety and liability notice
This page documents and evaluates online community information. It is not medical or therapeutic advice, individual counselling or an invitation to use Ipamorelin. It is not approved for the uses described here.
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Quick context
Selank
Is researched for anxiety, stress and cognitive signalling; FDA/EMA approval and robust evidence are lacking.
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Amounts, timing and cycles
Community/research information only
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Amount status
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Timing
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycle/duration
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.
Reconstitution calculator
Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.
Concentration
3,333.33 µg/ml
Calculated volume
0.06 ml
U-100 units
6 U
Calculated portions per vial
50
Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.
Mechanism and research questions
Synthetic tuftsin-derived heptapeptide
Selank is classified as “Synthetic tuftsin-derived heptapeptide”. Is researched for anxiety, stress and cognitive signalling; FDA/EMA approval and robust evidence are lacking. This describes the investigated pathway but does not validate a community use, amount, route or combination.
01
Anxiolytic signalling
This studies how a peptide affects stress and anxiety responses in animal models, similar to observing whether an animal stays calmer in an unfamiliar environment. Behavioural tests and stress hormone levels are measured.
02
Neuroendocrine signalling
This examines how the nervous system and hormone-producing glands communicate with each other, similar to a two-way phone line connecting the brain to distant organs. Researchers typically measure hormone levels in blood alongside markers of nervous system activity.
03
Neuroprotective signalling
This examines whether a substance can protect nerve cells from stress or damage, such as after oxygen deprivation in a cell model. Cell survival and signalling markers in nerve tissue under lab conditions are measured.
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
Nootropic forums
Subjective effects on concentration, mood, or stress perception after taking experimental neuropeptides are discussed, often based on personal journals. Such self-reported impressions are strongly influenced by expectation and do not replace controlled studies.
Biohacker and longevity forums
Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.
Source and purity discussion
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Adverse effects and risk boundaries
Central nervous system effects may include fatigue, agitation, headache, dizziness, sleep or mood changes. Interactions and long-term neuropsychiatric safety are unclear for unapproved substances.
Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
Pregnancy, epilepsy, severe psychiatric or neurological disease, and sedating or stimulating concomitant medicines require medical review.
Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
Studies may track cognition, sleep, mood, vital signs and adverse events depending on the endpoint; daily subjective impressions do not replace standardised measurement.
Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
Preclinical
Robust clinical evidence and FDA/EMA approval are still lacking.
Published evidence
Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.
Selank is a tuftsin analogue and more associated with stress and anxiety research than the ACTH-derived Semax.
Storage and stability
The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
Not FDA/EMA approved
No FDA- or EMA-approved medicinal product; efficacy and safety are not established.
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.